This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Trending Stock KimberlyClark Corporation (KMB) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Kimberly-Clark (KMB). This makes it worthwhile to examine what the stock has in store.
Things to Note as Kimberly-Clark (KMB) Lines Up for Q2 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2022 results are likely to reflect elevated input costs, while pricing and saving efforts are likely to have aided the company.
Kimberly-Clark (KMB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Kimberly-Clark (KMB) closed at $130.55, marking a -0.61% move from the previous day.
Kimberly-Clark (KMB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Kimberly-Clark (KMB) closed the most recent trading day at $134.68, moving -0.33% from the previous trading session.
Kimberly-Clark (KMB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Kimberly-Clark (KMB) closed at $134.72, marking a +0.39% move from the previous day.
Is Most-Watched Stock KimberlyClark Corporation (KMB) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching Kimberly-Clark (KMB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Kimberly-Clark (KMB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Kimberly-Clark (KMB) closed at $136.09, marking a -0.49% move from the previous day.
Kimberly-Clark's (KMB) Saving Initiatives Aid Amid Rising Costs
by Zacks Equity Research
Kimberly-Clark (KMB) is focused on undertaking relevant cost-cutting initiatives and pricing actions to counter inflation. Management is committed to its three key strategic growth pillars.
Constellation Brands (STZ) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Constellation Brands (STZ) delivered earnings and revenue surprises of 5.98% and 7.99%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Kimberly-Clark (KMB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Kimberly-Clark (KMB) closed at $133.59 in the latest trading session, marking a -0.65% move from the prior day.
Kimberly-Clark (KMB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Kimberly-Clark (KMB) closed the most recent trading day at $121.79, moving +0.12% from the previous trading session.
Kimberly-Clark (KMB) Stock Moves -0.67%: What You Should Know
by Zacks Equity Research
In the latest trading session, Kimberly-Clark (KMB) closed at $126.91, marking a -0.67% move from the previous day.
Kimberly-Clark's (KMB) Strategic Growth Pillars & Savings Aid
by Zacks Equity Research
Kimberly-Clark (KMB) is committed to its three key strategic growth pillars. Management is focused on efficiently managing costs amid an inflationary environment.
Kimberly-Clark (KMB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Kimberly-Clark (KMB) closed at $132.10 in the latest trading session, marking a +0.17% move from the prior day.
Kimberly-Clark (KMB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Kimberly-Clark (KMB) closed at $131.40, marking a -1.22% move from the previous day.
Kimberly-Clark's (KMB) Saving Efforts Aid Amid Rising Costs
by Zacks Equity Research
Kimberly-Clark's (KMB) efficient cost-saving efforts are yielding amid rising input costs. Also, the company is committed to its three key strategic growth pillars.
Company News for Apr 25, 2022
by Zacks Equity Research
Companies in The News Are: SLB,HCA,KMB,NEM
Kimberly-Clark (KMB) Q1 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2022 earnings decline year over year. Nevertheless, sales increased on growth across all segments.
Kimberly-Clark (KMB) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Kimberly-Clark (KMB) delivered earnings and revenue surprises of 9.76% and 3.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Kimberly-Clark (KMB) Queued for Q1 Earnings: Things to Note
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2022 performance is likely to reflect higher input cost inflation and supply-chain disruptions. Nevertheless, cost-saving efforts bode well.
Earnings Preview: Kimberly-Clark (KMB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Kimberly-Clark (KMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kimberly-Clark (KMB) Faces High Costs, Down Over 10% in 3 Months
by Zacks Equity Research
Kimberly-Clark (KMB) is battling high input costs for the past few quarters. Soft sales in the company's Consumer Tissue segment are also a concern.
Chewy (CHWY) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Chewy (CHWY) delivered earnings and revenue surprises of -57.14% and 1.58%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
ACI or KMB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACI vs. KMB: Which Stock Is the Better Value Option?
Why Is Kimberly-Clark (KMB) Down 6.5% Since Last Earnings Report?
by Zacks Equity Research
Kimberly-Clark (KMB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.